Two businesses under one roof, and only one of them is billed to insurance.
Optometry blends exam revenue with an optical dispensary, and the two follow completely different rules. Vision plan economics, capture rate, and inventory decide the margin, while exam volume decides the traffic. The monthly briefing reads both halves separately and then together, so you can tell whether a soft month came from the chair, the counter, or the plan mix.
Where the specialty stands
Optometry is part medical practice, part retail business, with optical capture rate and managed-vision plan participation defining most P&Ls. Myopia management and dry-eye programs are growing as ancillary medical lines while private equity continues to roll up larger MD/OD groups.
- Myopia management (atropine, ortho-K, soft myopia control lenses) is shifting pediatric optometry from refraction-only to an ongoing clinical service.
- Dry-eye dedicated clinics and IPL/RF devices have become a meaningful ancillary revenue line for many practices.
- Vision-plan economics (VSP, EyeMed) keep tightening. Capture rate and lab strategy may matter more than chair time.
- MD/OD integrated groups are scaling through PE platforms; pure-OD independents are sharpening differentiation through medical optometry.
- Telehealth refraction and online retailers are competitive pressure on the optical side, not the medical side.
What the briefing reads for a optometry practice
Exams per day, open slots, and no-show behavior. The chair schedule sets the ceiling for everything that happens at the optical counter.
Share of exam patients who purchase, average order value, and second-pair rate, read against cost of goods rather than gross sales.
Plan mix, allowed amounts, and the medical eye care share of visits. Plan reimbursement and frame allowances can quietly compress margin on otherwise healthy volume.
Frame inventory turns, aged stock, and lab cost per job. Capital sitting in slow frames is capital not available for equipment or staffing.
Dry eye, myopia management, and other medical services tracked separately, since they carry different reimbursement and different chair time.
Illustrative reference ranges
Read the methodologyThese internally authored, industry-informed estimates provide specialty context. They are not live peer data, licensed survey medians, targets, or promises.
| Indicator | Lower reference | Central reference | Upper reference |
|---|---|---|---|
| Revenue per provider (monthly) | $33k | $42k | $52k |
| Days in A/R | 20 days | 28 days | 36 days |
| Net collection rate | 92% | 95% | 97% |
| No-show rate | 5% | 7.5% | 10% |
| Operating expense ratio | 54% | 60% | 66% |
| Patient satisfaction | 4.3 / 5 | 4.6 / 5 | 4.8 / 5 |
| Contractual adjustment rate | 18% | 24% | 30% |
| Commercial payer mix | 42% | 55% | 68% |
| Average reimbursement rate | 52% | 60% | 68% |
| Third next available appointment | 4 days | 8 days | 14 days |
| Scheduling efficiency | 72% | 80% | 88% |
| Staff per provider | 3 | 3.6 | 4.2 |
| Provider turnover | 6% | 10% | 14% |
| Training investment (% of payroll) | 0.8% | 1.6% | 2.4% |
| Cost per visit | $120 | $145 | $180 |
| Quality compliance rate | 85% | 90% | 94% |
Questions this briefing is built to answer
- What share of exam patients buy from us, and where do we lose the rest?
- Is our vision plan mix helping or hurting margin?
- How much capital is tied up in frames that are not moving?
- Is medical eye care growing fast enough to offset plan reimbursement pressure?
- What does an open chair slot cost us once optical is included?
- Is our staffing right for both the exam lane and the optical floor?
What we read to stay current
See what this looks like for your practice
Send aggregate practice data for a recent period and we will show you the executive brief format: what changed, why it may matter, likely drivers, and what to watch.
AileronMD analyzes business, financial, and operational data only. Do not submit patient records or protected health information. AileronMD does not provide clinical or medical advice, and does not guarantee financial results. Guidance is advisory; practice leadership makes the decisions.